By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Enzyvant Sciences Ltd. 



Basel      Switzerland
Phone: n/a Fax: n/a


SEARCH JOBS

Enzyvant is a new biopharmaceutical company formed by Roivant Sciences and Plexcera Therapeutics focused on the treatment of patients with Farber disease, a rare lysosomal storage disease. Enzyvant is completing pre-clinical studies for recombinant human acid ceramidase (rhAC), an enzyme replacement therapy, to enable a clinical trial in patients with Farber disease.

LEADERSHIP:

CEO: Alvin Shih


Key Statistics


Email: info@enzyvant.com
Ownership: Private

Web Site: Enzyvant Sciences
Employees:
Symbol: 
 









Company News
//-->